Iron out for nontransfused thalassemia. (apre una nuova finestra)

Marks PW.

Fonte‎: Blood 2012;120(5):928-9.

Indicizzato‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (apre una nuova finestra)

Iron overload in β-thalassemia intermedia: an emerging concern. (apre una nuova finestra)

Musallam KM, Cappellini MD, Taher AT.

Fonte‎: Curr Opin Hematol 2013;20(3):187-92.

Indicizzato‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (apre una nuova finestra)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (apre una nuova finestra)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Fonte‎: Blood 2012;120(7):1531-2.

Indicizzato‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (apre una nuova finestra)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (apre una nuova finestra)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Fonte‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indicizzato‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (apre una nuova finestra)

Therapeutic roles of curcumin: lessons learned from clinical trials. (apre una nuova finestra)

Gupta SC, Patchva S, Aggarwal BB.

Fonte‎: AAPS J 2013;15(1):195-218.

Indicizzato‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (apre una nuova finestra)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (apre una nuova finestra)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Fonte‎: J Med Assoc Thai 2012;95(1):29-36.

Indicizzato‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (apre una nuova finestra)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (apre una nuova finestra)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Fonte‎: Am J Hematol 2013;88(6):503-6.

Indicizzato‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (apre una nuova finestra)